English
Insider transactions
EDGARBrainstorm Cell Therapeutics Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–13 of 13
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 Filed 2026-07-28 | FRENKEL JACOB A Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 343,777 | Direct (D) | No | F1
| Open filing 0001104659-26-087588 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Pitts Peter Joe Director · Officer: Executive Chairman | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 900,000 | 0 | — | 900,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-087584 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-29 | FRENKEL JACOB A Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 200,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 243,777 | Direct (D) | No | F1
| Open filing 0001104659-26-068336 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-29 | Lebovits Chaim Officer: President CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,800,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 2,000,960 | Direct (D) | No | F1
| Open filing 0001104659-26-068339 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-29 | Patlis Alla Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 144,349 | Direct (D) | No | F1
| Open filing 0001104659-26-068337 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-29 | ARBEL IRIT Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 120,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 161,054 | Direct (D) | No | F1
| Open filing 0001104659-26-068335 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-29 | Yablonka Uri Director · Officer: EVP Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 150,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 218,464 | Direct (D) | No | F1
| Open filing 0001104659-26-068338 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-20 | Polverino Anthony J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 150,000 | 0.70 | 105,000Derived: shares × price per share. Exact value 105000.00. | 150,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-064657 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-20 | Naor Nir Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 180,000 | 0.70 | 126,000Derived: shares × price per share. Exact value 126000.00. | 180,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-064652 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-20 | HARTOUNIAN HARTOUN Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 225,000 | 0.70 | 157,500Derived: shares × price per share. Exact value 157500.00. | 225,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-064656 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-20 | Bairu Menghisteab Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 150,000 | 0.70 | 105,000Derived: shares × price per share. Exact value 105000.00. | 150,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-064658 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-20 | Lindborg Stacy Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 150,000 | 0.70 | 105,000Derived: shares × price per share. Exact value 105000.00. | 150,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-064653 Read from the filing’s XML Dispute this row |
| 2026-02-26 Filed 2026-05-20 | Dagher Ibrahim B. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 225,000 | 0.70 | 157,500Derived: shares × price per share. Exact value 157500.00. | 225,000 | Direct (D) | No | F1, F2
| Open filing 0001104659-26-064650 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
No Schedule 13D or 13G naming this issuer is in the store; this is not a statement that none were filed.
What was read
2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 103,592 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,124 |
Filings made before the SEC required XML are listed, not extracted.